Name
How Berg + Mt. Sinai Are Innovating to Fulfill the Promise of Precision Medicine
Date & Time
Wednesday, November 2, 2016, 9:30 AM - 11:00 AM
Description
Davis Auditorium at the Hess Center for Science and Medicine
Mount Sinai Medical Center, 1470 Madison Avenue, New York, NY 10029
Mount Sinai Medical Center, 1470 Madison Avenue, New York, NY 10029
Stop by Mount Sinai’s Icahn School of Medicine for a conversation with Berg CEO Niven Narain; Dr. Eric Nestler, MD, Ph.D., chair of neuroscience at the school; and Dr. Eric Schadt, Ph.D., chair of genetics and genomics, on how artificial intelligence, big-data analytics, and genomics are accelerating drug discovery and getting treatments into patients' hands more quickly. Ultimately, this conversation will reveal the ways that various innovations from biopharma companies like Berg are beginning to deliver on the promise of “precision medicine” to identify the right drug, for the right patient, at the right time.
Session
How Berg + Mt. Sinai Are Innovating to Fulfill the Promise of Precision Medicine
Hosted by NIVEN NARAIN, CEO, BERG; ERIC NESTLER, M.D., Ph.D., Professor and Chair of Neuroscience at the Icahn School of Medicine at Mount Sinai; and ERIC SCHADT, Ph.D., Professor and Chair of Genetics and Genomic Sciences and Director at the Icahn School of Medicine Institute for Genomics and Multiscale Biology
Hosted by NIVEN NARAIN, CEO, BERG; ERIC NESTLER, M.D., Ph.D., Professor and Chair of Neuroscience at the Icahn School of Medicine at Mount Sinai; and ERIC SCHADT, Ph.D., Professor and Chair of Genetics and Genomic Sciences and Director at the Icahn School of Medicine Institute for Genomics and Multiscale Biology
Session Type
Fast Track
Theme
Tech
Location
Davis Auditorium at the Hess Center for Science and Medicine
Mount Sinai Medical Center, 1470 Madison Avenue, New York, NY 10029
Mount Sinai Medical Center, 1470 Madison Avenue, New York, NY 10029
The Hess Center for Science and Medicine Mount Sinai Medical Center
Stop by Mount Sinai’s Icahn School of Medicine for a conversation with Berg CEO Niven Narain; Dr. Eric Nestler, MD, Ph.D., chair of neuroscience at the school; and Dr. Eric Schadt, Ph.D., chair of genetics and genomics, on how artificial intelligence, big-data analytics, and genomics are accelerating drug discovery and getting treatments into patients' hands more quickly. Ultimately, this conversation will reveal the ways that various innovations from biopharma companies like Berg are beginning to deliver on the promise of “precision medicine” to identify the right drug, for the right patient, at the right time.